Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
EV/EBIT

    Back to All Ratios
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 27.3647.7027.698.479.60

What is the latest EV/EBIT ratio of GLENMARK PHARMACEUTICALS ?

The latest EV/EBIT ratio of GLENMARK PHARMACEUTICALS is 27.36 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar202527.36
Mar202447.70
Mar202327.69
Mar20228.47
Mar20219.60

How is EV/EBIT of GLENMARK PHARMACEUTICALS Trending?

Years EV/EBIT % Change
Mar2025 27.36
-42.64
Mar2024 47.7
72.26
Mar2023 27.69
226.92
Mar2022 8.47
-11.77
Mar2021 9.6 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare EV/EBIT ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹59,720.6 Cr 5.5% 2.6% 20.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹382,718.0 Cr 1% -0.2% -13.4% Stock Analytics
DIVIS LABORATORIES ₹159,282.0 Cr -2.7% -2.2% 17.6% Stock Analytics
CIPLA ₹125,351.0 Cr -1.7% 4.1% -5.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹123,267.0 Cr 1% 1.3% 4.9% Stock Analytics
DR REDDYS LABORATORIES ₹107,952.0 Cr 2.5% 7.7% -6.7% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

5.5%

2.6%

20.1%

SENSEX

1.2%

0.7%

-1.5%


You may also like the below Video Courses